Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Balducci, L; Lyman, GH

Published Date

  • March 1, 2001

Published In

Volume / Issue

  • 19 / 5

Start / End Page

  • 1583 - 1585

PubMed ID

  • 11230505

Pubmed Central ID

  • 11230505

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/JCO.2001.19.5.1583

Language

  • eng

Conference Location

  • United States